U.S. Hotel and Resort REITs Stock News

NYSE:MKL
NYSE:MKLInsurance

How Markel’s New Analytics Chief Could Reshape Risk Selection and Pricing for Markel Group (MKL) Investors

On March 10, 2026, Markel Insurance appointed Kristen Dardia as Head of Portfolio Analytics for the US and Bermuda, tasking her with leading advanced analytics, technical pricing, and portfolio management after nearly two decades in actuarial science, analytics, and business strategy. Her track record embedding analytics into underwriting and portfolio decisions could meaningfully influence how Markel Group refines risk selection and pricing across its specialty insurance operations. Next,...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

CSX Select Site Growth And Owens Corning Deal Shape Valuation View

CSX expanded its Select Site initiative by awarding its designation to 21 new rail served properties across 10 states. Owens Corning announced a large manufacturing investment at a CSX Silver Select Site in Alabama, tied to about 100 new skilled jobs. This development reflects fresh industrial interest in CSX served locations, beyond recent discussions focused on valuation, margin outlook, and service metrics for NasdaqGS:CSX. For investors tracking NasdaqGS:CSX, this move adds a fresh...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Assessing Insulet (PODD) Valuation After Omnipod 5 Tubing Defect And Ongoing Product Replacements

Insulet (PODD) is in focus after disclosing an internal tubing defect in certain Omnipod 5 Pod lots, prompting a voluntary Medical Device Correction and free replacements. Production and new patient starts are expected to continue. See our latest analysis for Insulet. The tubing defect news has landed against a weak recent share price backdrop, with the 90 day share price return at a 20.4% decline and the 1 year total shareholder return at an 11.5% loss. This suggests that momentum has been...
NasdaqCM:ALDX
NasdaqCM:ALDXBiotechs

Aldeyra Therapeutics (ALDX) Is Down 75.2% After FDA Rebuffs Dry Eye Drug Efficacy Data - Has The Bull Case Changed?

In March 2026, Aldeyra Therapeutics reported that the FDA issued a Complete Response Letter for its reproxalap dry eye disease NDA, citing insufficient and inconsistent evidence of efficacy despite no safety or manufacturing concerns. An important nuance is that the FDA did not request new trials, instead urging Aldeyra to clarify why certain studies failed and where reproxalap might work best. We’ll now examine how the FDA’s efficacy concerns and lack of requested new trials reshape...
NYSE:R
NYSE:RTransportation

Surging Tender Rejections and Tightening Truck Capacity Might Change The Case For Investing In Ryder System (R)

In early 2026, a joint SONAR and Ryder System report showed tender rejection rates climbing to nearly 14.3% in early February, reaching levels last seen during the pandemic and pointing to tightening trucking capacity. This spike in rejection rates hints at a shifting freight balance that could influence pricing power and operational conditions for logistics providers like Ryder. We’ll now examine how this jump in tender rejection rates could influence Ryder’s existing investment narrative...
NasdaqGS:PI
NasdaqGS:PISemiconductor

Did Impinj’s (PI) Convertible Note Buyback Just Quietly Reshape Its Capital Structure Story?

Impinj recently entered privately negotiated agreements to repurchase approximately US$40.2 million of its 1.125% convertible notes due 2027 for cash, leaving about US$57.3 million outstanding after the March 16, 2026 closing. This sizable debt repurchase alters Impinj’s capital structure and could influence how investors assess its balance sheet strength and financial flexibility. Next, we’ll examine how Impinj’s sizable convertible note repurchase affects its existing investment narrative...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

Alnylam’s Cardiovascular RNAi Collaboration With Tenaya Might Change The Case For Investing In ALNY

Earlier this month, Tenaya Therapeutics announced a research collaboration with Alnylam Pharmaceuticals to validate up to 15 gene targets for cardiovascular disease, receiving an upfront US$10 million payment, cost reimbursement over two years, and eligibility for as much as US$1.13 billion in development and commercial milestones. The collaboration highlights Alnylam’s effort to extend its RNAi platform into cardiovascular indications while outsourcing early target validation to a...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

Is It Too Late To Consider Rhythm Pharmaceuticals (RYTM) After Its 4x Three Year Surge?

If you are wondering whether Rhythm Pharmaceuticals at around US$87.68 is still reasonably priced after its run, you are not alone. This article takes a closer look at what that level might mean for value focused investors. The stock has seen a 5.7% decline over the past week and a 10.6% decline over the last month, even after a 67.7% return over the past year and a very large gain over three years of about 4x. Recent coverage has highlighted investor interest following these sizeable multi...
NYSE:RNST
NYSE:RNSTBanks

A Look At Renasant (RNST) Valuation After Recent Share Price Weakness

Renasant (RNST) has drawn fresh attention after its recent share performance, with the stock down about 13% over the past month and 5% over the past 3 months, despite positive 1 year total returns. See our latest analysis for Renasant. The recent 13.4% 1 month share price decline, on top of a 5.4% 3 month share price fall, contrasts with Renasant's 4.6% 1 year total shareholder return. This suggests near term momentum is fading even as longer term investors remain modestly ahead. If you are...
NYSE:BKE
NYSE:BKESpecialty Retail

Evaluating Buckle (BKE) After Earnings Reveal Higher Sales And Net Income

Earnings event puts Buckle in focus Buckle (BKE) is back on investors’ radar after reporting Q4 and full year 2026 results, with higher sales and net income across both periods compared with the previous year. The fresh numbers give you an updated snapshot of how this apparel retailer is converting its store base and online presence into revenue and earnings, which can be useful context if you already hold the stock or track the retail sector. See our latest analysis for Buckle. The recent Q4...
NYSE:TALO
NYSE:TALOOil and Gas

Is It Too Late To Consider Talos Energy (TALO) After A 57% One Year Rally?

If you are wondering whether Talos Energy at around US$13.96 is still offering value or if you might be late to the story, this breakdown will help you put the current share price into context. The stock has seen a 7.9% return over the last 7 days, 6.4% over the last 30 days, 24.1% year to date, and 56.9% over the past year, which can influence how investors think about both upside and risk. Recent coverage around Talos Energy has focused on its position in the US energy sector and how the...
NYSE:JCI
NYSE:JCIBuilding

Johnson Controls Resets Portfolio Toward AI Data Centers And Services

Johnson Controls International (NYSE:JCI) has agreed to sell its residential HVAC business to Bosch, reallocating focus toward data center and service solutions. The company is expanding offerings for AI oriented data centers, including a partnership with NVIDIA to support advanced cooling needs. Management has highlighted backlog growth as evidence of strong demand for these focus areas. For investors tracking NYSE:JCI, this shift comes with the stock at $132.56 and a 1 year return of...
NYSE:AEM
NYSE:AEMMetals and Mining

Agnico Eagle Diesel Hedges Support Margins As Fuel Costs Rise

Rising oil and diesel prices are increasing operating costs for gold miners, including Agnico Eagle Mines. NYSE:AEM has hedged a meaningful portion of its diesel exposure, helping protect its cost structure and profit margins. This hedging approach is setting Agnico Eagle apart from peers facing similar inflation pressures without the same level of protection. Agnico Eagle Mines, NYSE:AEM, is drawing attention as higher fuel costs ripple through the gold mining sector. With shares at...
NYSE:COOK
NYSE:COOKConsumer Durables

Does Traeger's Reverse Stock Split To Regain NYSE Compliance Change The Bull Case For COOK?

Traeger, Inc. has already implemented a 1-for-50 reverse stock split on March 18, 2026, following stockholder approval earlier in the month to address a New York Stock Exchange notice that its shares had traded below US$1.00 for 30 consecutive trading days. This reverse split, combined with recent weak 2025 results and ongoing losses, highlights how Traeger is using financial tools rather than operational improvements alone to preserve its exchange listing. Next, we'll explore how Traeger's...
NYSE:DCH
NYSE:DCHAuto Components

Will Insider Buying and Summit Spotlight Change Dauch's (DCH) Narrative?

Earlier in March 2026, Dauch Corporation announced it would present at the Bank of America Global Automotive Summit on March 17, and SEC filings revealed Director David Walker bought 35,000 company shares, bringing his total holdings to 35,000 shares. This combination of a high-profile investor conference appearance and fresh insider buying drew attention to how leadership is positioned alongside shareholders. Next, we’ll examine how Director David Walker’s insider share purchase may...
NasdaqGS:ZBIO
NasdaqGS:ZBIOBiotechs

Zenas BioPharma (ZBIO) Is Down 9.4% After Non-Dilutive Funding And Shelf Filing Update - Has The Bull Case Changed?

In March 2026, Zenas BioPharma reported a wider quarterly and full-year net loss alongside higher revenue, while also securing up to US$250,000,000 in non-dilutive term loan financing and filing a US$78,589,885 shelf registration linked to an ESOP-related common stock offering. This combination of a larger loss, incremental revenue from partnerships, and substantial new funding reshapes how the company can support obexelimab’s commercialization plans and broader pipeline activities. With...
NYSE:AIR
NYSE:AIRAerospace & Defense

Does Trax Powering Magnifica Air’s Paperless Maintenance Deepen AAR’s Recurring Digital Moat (AIR)?

AAR announced that its Trax subsidiary previously agreed to provide Magnifica Air with cloud-hosted eMRO and eMobility solutions, enabling fully paperless maintenance and engineering operations from the airline’s launch. This deal underscores how AAR’s software can become embedded in airlines’ day-to-day maintenance workflows, potentially deepening customer relationships and recurring digital revenue streams. Next, we’ll examine how Trax’s role in enabling Magnifica Air’s paperless...
NYSE:KBR
NYSE:KBRProfessional Services

What KBR (KBR)'s Long-Term Jubail Maintenance Deal Means For Shareholders

KBR recently announced it had secured a seven-year General Maintenance Services contract, with an optional three-year extension, from Saudi Aramco Total Refining and Petrochemical Company for its petrochemical expansion complex in Jubail, Saudi Arabia, covering preventive, predictive, corrective and shutdown maintenance across the site. This long-term mandate extends more than a decade of collaboration with Saudi Aramco Total Refining and Petrochemical Company and underscores KBR’s role in...
NYSE:KMX
NYSE:KMXSpecialty Retail

How Investors May Respond To CarMax (KMX) Activist Push For Operational Efficiencies And Dynamic Pricing

On March 11, 2026, activist investor Starboard Value LP nominated Jeffrey C. Smith and William C. Cobb to CarMax’s board and pressed the company to accelerate operational improvements as incoming CEO Keith Barr begins his tenure. By coupling public support for Barr’s turnaround efforts with specific proposals on customer experience, refurbishment efficiency, costs, and pricing, Starboard is signaling pressure for tangible operational changes rather than broad governance tweaks. We’ll now...
NYSE:AXP
NYSE:AXPConsumer Finance

Should Amex’s Stadium Push and Higher Dividend Shape How AXP Investors View Its Capital Priorities?

Earlier this month, American Express announced long-term partnerships making it the Official Payments Partner of MetLife Stadium, Mercedes-Benz Stadium, several associated New York and Atlanta sports teams, and the future Atlanta NWSL club, while adding these venues to the American Express Venue Collection for enhanced Card Member benefits. At the same time, the company approved a 16% increase in its quarterly dividend to US$0.95 per share, highlighting an increased emphasis on returning...
NasdaqGS:STBA
NasdaqGS:STBABanks

A Look At S&T Bancorp (STBA) Valuation After Recent Share Price Pullback

What recent performance says about S&T Bancorp (STBA) S&T Bancorp (STBA) has seen mixed share performance lately, with a 0.5% decline over the past day, 1.3% over the past week, about 8.5% over the past month, and 5.7% over the past 3 months. Even with those recent pullbacks, the stock shows a 1.8% year to date total return and about 9.3% over the past year, while the 3 year and 5 year total returns sit near 34.3% and 52.5% respectively. See our latest analysis for S&T Bancorp. ST Bancorp's...
NYSE:EAT
NYSE:EATHospitality

How Investors Are Reacting To Brinker International (EAT) Earnings Beat And Unified Marketing Leadership Shift

Brinker International recently reported quarterly results that surpassed expectations and issued a strong fiscal-2026 outlook, while also elevating George Felix to Executive Vice President and Chief Marketing Officer to oversee marketing for both Chili’s Grill & Bar and Maggiano’s Little Italy. Alongside this leadership consolidation, Chili’s expanded its brand reach through campaigns such as the Marg Machine NASCAR collaboration, which may influence how consistently the company presents its...
NYSE:TRN
NYSE:TRNMachinery

Did Trinity’s 248th Straight Dividend and EPS Beat Just Shift Its Capital Allocation Story (TRN)?

Trinity Industries has declared a quarterly dividend of US$0.31 per share on its US$0.01 par value common stock, marking its 248th consecutive dividend payment and scheduled for payment on April 30, 2026 to holders of record as of April 15, 2026. The dividend affirmation comes shortly after Trinity delivered full-year 2025 results that exceeded revenue expectations and improved EPS through higher lease rates, lease portfolio sale gains, lower administrative costs, and a non-cash benefit from...
NYSE:MD
NYSE:MDHealthcare

Will Rising Earnings Estimates and Growth Scores Change Pediatrix Medical Group's (MD) Narrative?

Pediatrix Medical Group, which rebranded from Mednax in 2022, has recently seen analysts raise earnings estimates and highlight its strong VGM and Growth Style Scores, alongside an earnings growth projection of 6.9% for the current fiscal year. Analysts are increasingly focusing on Pediatrix’s favorable payer mix, higher patient acuity in neonatology, and ongoing acquisitions as key supports for its long-term growth profile, despite risks such as lower birth rates and potential changes to...